Leqembi Pen (Subcutaneous Formulation Of Leqembi) Now Available In Japan For Patients With Early Alzheimer's Disease

BRIEF-Eisai Co., Ltd.- Leqembi Pen (Subcutaneous Formulation Of Leqembi) Now Available In Japan For Patients With Early Alzheimer's Disease

- Eisai Co., Ltd. 4523.T:

  • EISAI CO., LTD.: LEQEMBI PEN (SUBCUTANEOUS FORMULATION OF LEQEMBI) NOW AVAILABLE IN JAPAN FOR PATIENTS WITH EARLY ALZHEIMER'S DISEASE

Source text: ID:nTSwl8d03b

Further company coverage: 4523.T


(Reporting by Tokyo Newsroom)

((+81345201189;))

Recent news on Eisai

See all news